Although TDM can be regarded to be intuitively built on treat-to-target strategies (Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative) in IBD, which include clinical improvement, mucosal healing, or normalization of CRP, TDM is not included in these parameters [25,80,81,82]. Here, CRP is linked to inflammatory bowel disease.